Clinical Trial 37578

Winter Haven, FL 33880


Study Summary:

The primary objective to the study is to assess whether treatment with pemafibrate will prevent cardiovascular events in adults with type 2 diabetes who have elevated triglycerides and HDL-C and are at high risk for future cardiovascular events.


Qualified Participants Must:

• Be currently taking a statin for cholesterol control (if not currently taking a statin, must be intolerant to at least 2 statins)
• Be Diagnosed with type 2 diabetes or have an A1C greater than 6.5 or Glucose greater than 129
• Not currently be taking any fibrate medications


Qualified Participants May Receive:

- Compensation for time and travel expenses

- Lab work and study provided medication

- Physicals performed by a board certified physician


Clinical trials are medical research studies designed to test the safety and/or effectiveness of new investigational drugs, devices, or treatments in humans. These studies are conducted worldwide for a range of conditions and illnesses. Learn more about clinical research and participating in a study at About Clinical Trials.